Meningioma Clinical Trials

118 clinical trials for Meningioma across international registries, including 46 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma — RECRUITING · PHASE1
• IN10018 in Combination With Dalpiciclib for Progressive Meningiomas — RECRUITING · PHASE1
• A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma — RECRUITING · PHASE2
• A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma — RECRUITING · PHASE2
• Embolization for Meningioma — RECRUITING · NA
• Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors — RECRUITING · PHASE1
• Search for Circulating Tumour Cells in the Blood and/or Cerebrospinal Fluid in Patients With Recurrent Aggressive Meningiomas: Proof-of-concept Study — RECRUITING · NA
• Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures — RECRUITING · PHASE1
• Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical Trial — RECRUITING · PHASE2
• Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients — RECRUITING
• Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). — RECRUITING · PHASE1
• Cognitive Status After Removal of Skull Base Meningioma — RECRUITING
• Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors — RECRUITING
• Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted Sutures — RECRUITING · NA
• Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma — RECRUITING
• Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma — RECRUITING · NA
• Cabozantinib for Patients With Recurrent or Progressive Meningioma — RECRUITING · PHASE2
• Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors — RECRUITING · PHASE1
• Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2) — RECRUITING · PHASE2
• Abemaciclib in Newly Diagnosed Meningioma Patients — RECRUITING · PHASE2
• Plasma Extracellular Vesicles in Meningioma Patients — RECRUITING · NA
• Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE — RECRUITING · PHASE4
• 3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features — RECRUITING · NA
• Epigenetic Profiling and Liquid Biopsy: Perspectives for Personalized Medicine in Meningioma Patients - MIND — RECRUITING
• Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial — RECRUITING · PHASE2
• Evaluation of the CONVIVO System — RECRUITING · NA
• Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors — RECRUITING · PHASE1
• Robot-Assisted Neurovascular Intervention — RECRUITING · NA
• Liquid Biopsy Evaluation and Repository Development at Princess Margaret — RECRUITING
• 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. — RECRUITING · PHASE4
• HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer) — RECRUITING · NA
• Proton Versus Photon Radiotherapy in Adults With Primary Brain Tumors — RECRUITING · NA
• A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors — RECRUITING · PHASE1
• Translation and Validation of the MQOL Self-questionnaire Into French for Assessing Quality of Life in Patients With Meningiomas — RECRUITING
• Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma: — RECRUITING · NA
• The Impact of Endoscopic Endonasal Skull Base Surgery on Olfaction — RECRUITING
• Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide — RECRUITING · PHASE1
• Predictive Factors for Survival in Aggressive Meningiomas — RECRUITING · NA
• Somatostatin Receptor PET Imaging to Guide Radiotherapy Dose Escalation in High Risk Meningiomas. — RECRUITING · NA
• Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema — RECRUITING · PHASE2
• Cryoablation of Brain Neoplasm — RECRUITING · NA
• SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON) — RECRUITING
• Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology — RECRUITING
• TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas — RECRUITING · PHASE1
• Combination of Alpelisib and Trametinib in Progressive Refractory Meningiomas — RECRUITING · PHASE1
• Neurocognition After Radiotherapy in CNS- and Skull-base Tumors — RECRUITING · NA
• Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2) — NOT_YET_RECRUITING · PHASE2
• Selumetinib for NF2-Related Schwannomatosis — NOT_YET_RECRUITING · PHASE2
• Luvometinib in Combination With Serplulimab for NF2-Related Tumors — NOT_YET_RECRUITING · PHASE1
• PREselection of Patients at Risk for COgnitive DEcline After Radiotherapy Using Advanced MRI — ACTIVE_NOT_RECRUITING

Refine this search